ORIGINAL RESEARCH
Published on 04 Aug 2025
Inflammatory imbalance and activation deficits in T cells of myasthenia gravis patients revealed by proteomic profiling
doi 10.3389/fimmu.2025.1648020
- 789 views
- Frontiers in Immunology
- Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
- Research Topics
- Spotlight on Myasthenia Gravis: Pathomechanisms, diagnostic challenges and novel therapeutic targets
Spotlight on Myasthenia Gravis: Pathomechanisms, diagnostic challenges and novel therapeutic targets
4,044
Total downloads
18k
Total views and downloads
Articles
BRIEF RESEARCH REPORT
Published on 28 May 2025
Efficiency of cell-based assays in detecting AChR antibodies in myasthenia gravis sera with low antibody concentrations as determined by radioimmunoprecipitation assay
doi 10.3389/fimmu.2025.1459423
- 1,105 views
ORIGINAL RESEARCH
Published on 15 May 2025
Efficacy of MLN9708 (ixazomib) in experimental autoimmune myasthenia gravis and in anti-AChR producing primary thymic cell cultures from myasthenia gravis patients
doi 10.3389/fimmu.2025.1521432
- 1,504 views
BRIEF RESEARCH REPORT
Published on 14 Apr 2025
Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience
doi 10.3389/fimmu.2025.1562419
- 1,619 views
ORIGINAL RESEARCH
Published on 08 Apr 2025
The burden of disease in seronegative myasthenia gravis: a patient-centered perspective
doi 10.3389/fimmu.2025.1555075
- 2,470 views
- 1 citation
ORIGINAL RESEARCH
Published on 31 Mar 2025
Development of a refined experimental mouse model of myasthenia gravis with anti-acetylcholine receptor antibodies
doi 10.3389/fimmu.2025.1521382
- 2,621 views
ORIGINAL RESEARCH
Published on 23 Dec 2024
Cutoffs on severity metrics for minimal manifestations or better status in patients with generalized myasthenia gravis
doi 10.3389/fimmu.2024.1502721
- 2,129 views
- 2 citations
REVIEW
Published on 05 Dec 2024
A clinical perspective on muscle specific kinase antibody positive myasthenia gravis
doi 10.3389/fimmu.2024.1502480
- 2,374 views
